For that reason, concomitant use should only be viewed as when other procedure options are not possible.No dose adjustment is necessary in people with mild and moderate hepatic impairment. BELSOMRA has not been studied in people with severe hepatic impairment and isn't encouraged for these sufferers.Warning individuals having BELSOMRA 20 mg in op